US$ 28.97
glp 1 agonist brand names india Eli Lilly launches weight-loss drug Mounjaro in India, beats Novo Nordisk to major market Beyond obesity: How weight loss
Description
Recognizing the potential of semaglutide for weight management, researchers developed Wegovy, a higher-dose version of semaglutide approved in 2021 explicitly for chronic weight management in patients with obesity or overweight with at least one weight-related comorbidity

Mol Metabol

2024;48:S181S206
Important Note: It's best to work with a registered dietitian or nutritionist to create a personalized meal plan that meets your individual needs and preferences

Liraglutide: A glucagon-like peptide-1 agonist for chronic weight management
